NCT06830590Recruiting
Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
Source: ClinicalTrials.gov · Last updated 13 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 11 Feb 2025
- Start date
- 1 Feb 2016
- Primary completion date
- 30 Dec 2025
- Lead sponsor
- Liaquat University of Medical & Health Sciences
- Diseases
- Childhood cancers
- NCT number
- NCT06830590
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Feb 2016 to the primary completion date, 30 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients received pre-operative chemotherapy or radiotherapy
Who the study is looking for
- Women with confirmed diagnosis of breast cancer without history of taking neoadjuvant therapy Good quality tumour samples available for IHC
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Binafsha M Syed Coordinator of this site? Confirm its status | Jamshoro | Pakistan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.